Su Wan Qing

Su Wan Qing currently serves as the Chief Financial Officer at ChromaDex, a bioscience company focused on healthy aging and the study of nicotinamide adenine dinucleotide (NAD+). Prior to this role, Su Wan Qing held various positions at Mattel, Inc., including Director of Corporate Financial Planning & Analysis, where responsibilities included leading annual planning processes and driving alignment on growth objectives across major brands and markets. Su Wan Qing also served as Senior Manager in both Corporate Financial Planning & Analysis and Investor Relations, overseeing communication with the financial community, managing earnings calls, and executing analyst events. Additionally, experience includes a role as a Results Analyst at Capital Guardian Trust Company, servicing institutional clients with investment strategies. Academic qualifications include an MBA in Economics and Statistics from USC Marshall School of Business, and an undergraduate degree from Sun Yat-sen University.